NAFLD and Hepatitis B
Nonalcoholic fatty liver disease (NAFLD) continues to receive global attention as it is one of the leading causes of cirrhosis and hepatocellular carcinoma. The study “Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease” aimed to examine the impact of previous Hepatitis B virus infection on the severity and outcomes of patients with NAFLD. It showed that NAFLD patients with positive anti-hepatitis B core antibody had a higher incidence of significant fibrosis and cirrhosis. (Am J Gastroenterol. 2020 Mar 9. doi: 10.14309/ajg.0000000000000588. [Epub ahead of print] )
Anyone interested in future collaboration in this field of research is welcome to contact our key investigator Prof Vincent Wong in the Department of Medicine and Therapeutics, CUHK. Prof Wong’s research focuses on non-invasive assessment and treatment of chronic liver diseases.